90 related articles for article (PubMed ID: 8917362)
1. Ca2+ mobilization during cell death induction by sodium 5, 6-benzylidene-L-ascorbate.
Takahashi H; Sakagami H; Ohata H; Iida M; Momose K; Yamamura M; Takeda M
Anticancer Res; 1996; 16(5A):2629-34. PubMed ID: 8917362
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific cytotoxicity and type of cell death induced by sodium 5,6-benzylidene-L-ascorbate.
Kishino K; Hashimoto K; Amano O; Kochi M; Liu WK; Sakagami H
Anticancer Res; 2008; 28(5A):2577-84. PubMed ID: 19035281
[TBL] [Abstract][Full Text] [Related]
3. Relationship between ascorbyl radical intensity and apoptosis-inducing activity.
Sakagami H; Satoh K; Ohata H; Takahashi H; Yoshida H; Iida M; Kuribayashi N; Sakagami T; Momose K; Takeda M
Anticancer Res; 1996; 16(5A):2635-44. PubMed ID: 8917363
[TBL] [Abstract][Full Text] [Related]
4. Induction of cell death by ascorbic acid derivatives in human renal carcinoma and glioblastoma cell lines.
Makino Y; Sakagami H; Takeda M
Anticancer Res; 1999; 19(4B):3125-32. PubMed ID: 10652601
[TBL] [Abstract][Full Text] [Related]
5. Induction of DNA fragmentation in human myelogenous leukemic cell lines by sodium 5,6-benzylidene-L-ascorbate and its related compounds.
Kuribayashi N; Sakagami H; Sakagami T; Niimi E; Shiokawa D; Ikekita M; Takeda M; Tanuma S
Anticancer Res; 1994; 14(3A):969-76. PubMed ID: 8074500
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of the antitumor action between sodium 5,6-benzylidene-L-ascorbate and sodium ascorbate (minireview).
Sakagami H; Satoh K; Kochi M
Anticancer Res; 1997; 17(6D):4451-2. PubMed ID: 9494548
[TBL] [Abstract][Full Text] [Related]
7. Calcium mobilization during nicotine-induced cell death in human glioma and glioblastoma cell lines.
Yamamura M; Amano Y; Sakagami H; Yamanaka Y; Nishimoto Y; Yoshida H; Yamaguchi M; Ohata H; Momose K; Takeda M
Anticancer Res; 1998; 18(4A):2499-502. PubMed ID: 9703899
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial control of cell death induction by sodium 5,6-benzylidene-L-ascorbate.
Fujii H; Amano O; Kochi M; Sakagami H
Anticancer Res; 2003; 23(2B):1353-6. PubMed ID: 12820394
[TBL] [Abstract][Full Text] [Related]
9. Interaction between sodium 5,6-benzylidene-L-ascorbate and gallic acid.
Koyama N; Satoh K; Ida Y; Hiroi M; Oi T; Kochi M; Yamamoto Y; Sakagami H
Anticancer Res; 1999; 19(2A):1159-64. PubMed ID: 10368669
[TBL] [Abstract][Full Text] [Related]
10. Role of hydrogen peroxide for cell death induction by sodium 5,6-benzylidene-L-ascorbate.
Tajima M; Toguchi M; Kanda Y; Kunii S; Hosaka M; Arakawa H; Maeda M; Satoh K; Asano K; Kochi M; Sakagami H
Anticancer Res; 1998; 18(3A):1697-702. PubMed ID: 9673392
[TBL] [Abstract][Full Text] [Related]
11. Interaction between sodium 5,6-benzylidene-L-ascorbate and dopamine.
Satoh K; Ida Y; Kochi M; Sakagami H
Anticancer Res; 1998; 18(5A):3565-9. PubMed ID: 9858940
[TBL] [Abstract][Full Text] [Related]
12. Induction of non-apoptotic cell death by sodium 5,6-benzylidene-L-ascorbate in a human salivary gland tumor cell line.
Sakagami H; Kusama K; Toguchi M; Kochi M
Anticancer Res; 1999; 19(5B):4045-8. PubMed ID: 10628352
[TBL] [Abstract][Full Text] [Related]
13. Sodium 5, 6-benzylidene-L-ascorbate induces in vitro neuronal cell differentiation accompanying apoptosis and necrosis.
Tashiro F; Sugiyama A; Urano Y; Kochi M
Anticancer Res; 2002; 22(3):1423-31. PubMed ID: 12168819
[TBL] [Abstract][Full Text] [Related]
14. Role of hydrogen peroxide in cytotoxicity induction by ascorbates and other redox compounds.
Iwasaka K; Koyama N; Nogaki A; Maruyama S; Tamura A; Takano H; Takahama M; Kochi M; Satoh K; Sakagami H
Anticancer Res; 1998; 18(6A):4333-7. PubMed ID: 9891488
[TBL] [Abstract][Full Text] [Related]
15. Uncoupling of incorporation of ascorbic acid and apoptosis induction.
Amano Y; Sakagami H; Tanaka T; Yamanaka Y; Nishimoto Y; Yamaguchi M; Takeda M
Anticancer Res; 1998; 18(4A):2503-6. PubMed ID: 9703900
[TBL] [Abstract][Full Text] [Related]
16. Production of hydrogen peroxide in cancerous tissue by intravenous administration of sodium 5,6-benzylidene-L-ascorbate.
Asano K; Satoh K; Hosaka M; Arakawa H; Inagaki M; Hisamitsu T; Maeda M; Kochi M; Sakagami H
Anticancer Res; 1999; 19(1A):229-36. PubMed ID: 10226547
[TBL] [Abstract][Full Text] [Related]
17. Changes in intracellular concentrations of amino acids and polyamines during the apoptosis of HL-60 cells.
Sakagami H; Fujiwara E; Yokote Y; Akahane K; Asano K; Kochi M; Hara E; Shirahata A
Anticancer Res; 2000; 20(1A):265-70. PubMed ID: 10769665
[TBL] [Abstract][Full Text] [Related]
18. Stability of sodium 5,6-benzylidene-L-ascorbate.
Sakagami H; Yamamura TS; Takahashi H; Shibuya I; Takeda M
Anticancer Res; 1995; 15(4):1269-74. PubMed ID: 7654007
[TBL] [Abstract][Full Text] [Related]
19. Modulating factors of radical intensity and cytotoxic activity of ascorbate (review).
Sakagami H; Satoh K
Anticancer Res; 1997; 17(5A):3513-20. PubMed ID: 9413196
[TBL] [Abstract][Full Text] [Related]
20. Effect of glutathione-modulating compounds on platinum compounds-induced cytotoxicity in human glioma cell lines.
Iida M; Doi H; Asamoto S; Sugiyama H; Sakagami H; Kuribayashi N; Takeda M; Okamura Y; Matsumoto K
Anticancer Res; 1999; 19(6B):5383-4. PubMed ID: 10697565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
